KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Humana (HUM) over the last 17 years, with Q3 2025 value amounting to $83.0 million.

  • Humana's Share-based Compensation rose 5660.38% to $83.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.0 million, marking a year-over-year increase of 3279.57%. This contributed to the annual value of $207.0 million for FY2024, which is 1828.57% up from last year.
  • Humana's Share-based Compensation amounted to $83.0 million in Q3 2025, which was up 5660.38% from $61.0 million recorded in Q2 2025.
  • Over the past 5 years, Humana's Share-based Compensation peaked at $83.0 million during Q3 2025, and registered a low of $33.0 million during Q4 2023.
  • Over the past 5 years, Humana's median Share-based Compensation value was $49.0 million (recorded in 2025), while the average stood at $51.1 million.
  • As far as peak fluctuations go, Humana's Share-based Compensation soared by 6666.67% in 2022, and later plummeted by 3375.0% in 2023.
  • Quarter analysis of 5 years shows Humana's Share-based Compensation stood at $48.0 million in 2021, then dropped by 10.42% to $43.0 million in 2022, then fell by 23.26% to $33.0 million in 2023, then skyrocketed by 63.64% to $54.0 million in 2024, then skyrocketed by 53.7% to $83.0 million in 2025.
  • Its Share-based Compensation stands at $83.0 million for Q3 2025, versus $61.0 million for Q2 2025 and $49.0 million for Q1 2025.